Safe Bulkers, Inc. Sets Date for the Third Quarter 2025 Results, Conference Call, and Webcast

Safe Bulkers, Inc. Sets Date for the Third Quarter 2025 Results, Conference Call, and Webcast GlobeNewswire November 19, 2025 Earnings Release: Tuesday, November 25, 2025, After Market Closes Conference Call and Webcast: Wednesday, November 26, 2025, at 10:00 A.M. Eastern Time MONACO, Nov. 19, 2025 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the Company) (NYSE: SB), […]

SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart

SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart Significant milestone reached in advancing a driverless total artificial heart, strengthening Picard Medicals leadership in total artificial heart technology GlobeNewswire November 19, 2025 TUCSON, Ariz., Nov. 19, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company

Pyxis Tankers Announces Date for the Release of the Third Quarter 2025 Results

Pyxis Tankers Announces Date for the Release of the Third Quarter 2025 Results GlobeNewswire November 19, 2025 Maroussi, Greece, November 19, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international shipping company with a focus on the seaborne transportation of refined petroleum products and dry bulk commodities, today announced the following: We will

Cerence Beats Upper End of Guidance, Delivering Strong Fourth Quarter and Fiscal Year 2025 Results; Projects 8% Growth in Core Technology Business in FY26

Cerence Beats Upper End of Guidance, Delivering Strong Fourth Quarter and Fiscal Year 2025 Results; Projects 8% Growth in Core Technology Business in FY26 GlobeNewswire November 19, 2025 Headlines Q4 revenue of $60.6 million and FY25 revenue of $251.8 million, both above high end of guidance range; Q4 Net cash provided by operating activities of

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 19, 2025 SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will

Marex Group PLC (MRX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announces that investors with losses related to Marex Group plc (“Marex” or the “Company”) (NASDAQ:MRX) have opportunity to lead the securities fraud class action lawsuit. https://mma.prnewswire.com/media/1221557/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MAREX GROUP PLC (MRX), CLICK HEREBEFORE DECEMBER 8, 2025 (THE LEAD PLAINTIFF

Universal Technical Institute Reports Fiscal Year 2025 Fourth Quarter and Year-End Results

Met or surpassed fiscal year 2025 guidance ranges for revenue, net income, adjusted EBITDA, diluted EPS, and new student starts Universal Technical Institute, Inc.(NYSE: UTI), a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, reported financial results for the fiscal 2025 fourth quarter and the full year ended September 30, 2025.

Stride, Inc. (LRN) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announces that investors with losses related to Stride, Inc. (“Stride” or the “Company”) (NYSE:LRN) have opportunity to lead the securities fraud class action lawsuit. https://mma.prnewswire.com/media/1221557/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN STRIDE, INC. (LRN), CLICK HERE BEFORE JANUARY 12, 2026 (THE LEAD PLAINTIFF DEADLINE)

Fifth Circuit Revives Constitutional Claims in Jackson, Mississippi Water Crisis Class Action

Kershaw Talley Barlow, PC announces a major appellate victory in the class action arising from the Jackson, Mississippi water crisis. In a published opinion, the U.S. Court of Appeals for the Fifth Circuitreinstated key constitutional claims brought on behalf of Jackson residents exposed to drinking water containing elevated levels of lead and other contaminants. Kershaw

FDA GRANTS FULL APPROVAL TO AMGEN’S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER

Global Confirmatory Phase 3 DeLLphi-304 Trial Showed IMDELLTRA Reduced Risk of Death by 40% Compared to Chemotherapy Underscores IMDELLTRA as a Recognized Standard of Care Treatment for Patients With Extensive Stage Small Cell Lung Cancer That Has Progressed Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval

Scroll to Top